In clinical practice, an increase in the levels of tartrate-resistant acid Phosphatase 5b (TRAP 5b), deoxypyridinoline (DPD), and cross-linked N-telopeptide of type 1 collagen (NTXI) are considered strong markers for bone loss and decreased BMD (osteoporosis). Here, ACP5 is linked to osteoporosis.